Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
Adial Pharmaceuticals Inc (NASDAQ: ADIL) closed the day trading at $0.57 down -13.11% from the previous closing price of $0.66. In other words, the price has decreased by -$13.11 from its previous closing price. On the day, 0.83 million shares were traded.
Ratios:
For a better understanding of ADIL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.99 and its Current Ratio is at 1.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On October 30, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $5.
Stock Price History:
Over the past 52 weeks, ADIL has reached a high of $3.00, while it has fallen to a 52-week low of $0.57. The 50-Day Moving Average of the stock is -16.11%, while the 200-Day Moving Average is calculated to be -35.77%.
Shares Statistics:
A total of 7.90M shares are outstanding, with a floating share count of 7.76M. Insiders hold about 1.73% of the company’s shares, while institutions hold 7.27% stake in the company.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.19 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$0.9 and -$0.9 for the fiscal current year, implying an average EPS of -$0.9. EPS for the following year is -$1.0, with 1.0 analysts recommending between -$1.0 and -$1.0.
